首页|期刊导航|LabMed Discovery|Adoption paradox of artificial intelligence in computational pathology:a three-stage maturity model from algorithms to clinical integration

Adoption paradox of artificial intelligence in computational pathology:a three-stage maturity model from algorithms to clinical integrationOA

中文摘要

Foundation and multimodal models now match expert-level performance on many diagnostic,prognostic,and biomarker tasks in pathology.Yet only a handful of AI systems are used in routine clinical practice,and the products that have reached patients differ substantially from research prototypes.We define this mismatch as the adoption paradox of computational pathology.We first survey the technical landscape from task-specific deep learning to large unimodal foundation models,multimodal systems,and early agentic architectures.We then examine what has actually entered the clinic,identifying four product archetypes(digital pathology platforms,population scale cytology screening,assistive detection in surgical pathology,and quantitative immunohistochemistry scoring).Using a three stage maturity model algorithmic capability(Stage 1),system integration(Stage 2),and institutional adoption(Stage 3),we analyze the structural barriers that gate each transition.Three interconnected barriers explain most of the gap:(1)Data and infrastructure fragility[pre-analytical variability,scanner-induced domain shift,format fragmentation,annotation scarcity,manual quality control(QC)];(2)Workflow misalignment(cognitive rhythm of pathologists,automation bias,scenario-dependent latency);(3)Institutional trust deficits(shallow interpretability,incomplete prospective validation,unclear reimbursement,unsettled liability,and regulatory gaps for generative/adaptive systems).We outline system-level pathways for each stage,including infrastructure first,AI,workflow-embedded intelligence,and adaptive governance.Our central claim is that the next phase of progress will depend less on architectural novelty than on the slower institutional work that turns capability into clinical benefit.The framework provides an actionable lens for regulators,developers,and healthcare organizations to diagnose why a given AI system remains a prototype and what is needed to move it into routine use.

Lu Cai;Biwen Meng;Jie Huang;Guanyu Ding;Min Ju;Wenwen Wang;Shijie Deng;Liqin Lai;Jin Wang;Chunxue Yang;Miao Ruan;Shugong Xu;Chaofu Wang;Jingxin Liu;Qian Da

Department of Pathology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaSchool of AI and Advanced Computing,Xi’an Jiaotong‑Liverpool University,Suzhou 215123,Jiangsu,ChinaDepartment of Pathology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaNational Administration of Traditional Chinese Medicine,Beijing 100027,ChinaDepartment of Basic Education,Qingdao City University,Qingdao 266106,Shandong,ChinaDepartment of Electrical and Computer Engineering,Carnegie Mellon University,Pittsburgh 15213,Pennsylvania,USADepartment of Pathology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaDepartment of Pathology,Tongde Hospital of Zhejiang Province,Hangzhou 310012,ChinaDepartment of Pathology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaDepartment of Pathology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaDepartment of Pathology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaSchool of Advanced Technology,Xi’an Jiaotong‑Liverpool University,Suzhou 215123,Jiangsu,ChinaDepartment of Pathology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaSchool of AI and Advanced Computing,Xi’an Jiaotong‑Liverpool University,Suzhou 215123,Jiangsu,ChinaDepartment of Pathology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China

信息技术与安全科学

Artifical intelligence(AI)Computational pathologyAdoption paradoxClinical translationMaturity modelAI governanceWorkflow integration

《LabMed Discovery》 2026 (2)

P.4-16,13

jointly supported by the Shanghai Shenkang Hospital Development Center Clinical Technology Promotion and Optimization Management Project(Grant No.22026211)the Shanghai Jiao Tong University Intelligent Medical Health Research Program(Grant No.YG2024QNB06)the Suzhou Science and Technology Development Planning Programme(Grant No.ZXL2023171).

10.1016/j.lmd.2026.100130

评论